{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:49:08Z","timestamp":1777888148583,"version":"3.51.4"},"reference-count":41,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Rehabilitation Medicine"],"published-print":{"date-parts":[[2020,6,19]]},"abstract":"<jats:p>Botulinum Toxin (BoNT) is widely used to treat hypertonia in pediatric patients. Although serious adverse events (AEs) occur infrequently, they can lead to significant patient morbidity and mortality. This paper will discuss potential safety risks that may affect outcomes, medical comorbidities, medication dosing, targeting techniques, and muscle morphology. It is the responsibility of the physician to discuss risks and benefits regarding the use of BoNT and mitigate risks of AEs while maximizing the effectiveness of the medication.<\/jats:p>","DOI":"10.3233\/prm-200716","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T14:06:54Z","timestamp":1592316414000},"page":"195-199","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["A pragmatic approach to Botulinum Toxin safety"],"prefix":"10.1177","volume":"13","author":[{"given":"Joshua A.","family":"Vova","sequence":"first","affiliation":[{"name":"Department of Pediatric Physical Medicine and Rehabilitation, Children\u2019s Healthcare of Atlanta, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enoch","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Pediatric Physical Medicine and Rehabilitation, Children\u2019s Healthcare of Atlanta, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.780"},{"key":"e_1_3_2_3_2","unstructured":"Sentinel Event [Internet]. The Joint Commission; 2020. Available at: https:\/\/www.jointcommission.org\/en\/resources\/patient-safety-topics\/sentinel-event\/."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","unstructured":"O\u2019FlahertySJ JanakanV MorrowAM ScheinbergAM WaughMCA. Adverse events and health status following botulinum toxin type a injections in children with cerebral palsy. 2011 Feb; 53(2): 125-30. doi: 10.1111\/j.1469-8749.2010.03814.x.","DOI":"10.1111\/j.1469-8749.2010.03814.x"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","unstructured":"NaiduK SmithK SheedyM AdairB YuX GrahamHK. Systemic adverse events following botulinum toxin a therapy in children with cerebral palsy. 2010 Feb; 52(2): 139-44. doi: 10.1111\/j.1469-8749.2009.03583.x.","DOI":"10.1111\/j.1469-8749.2009.03583.x"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins7114645"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.13995"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.13686"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.13286"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2009.09.005"},{"key":"e_1_3_2_11_2","unstructured":"FDA Approves BOTOX\u00ae (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity Excluding Spasticity Caused by Cerebral Palsy [Internet]. AbbVie; 2019 Oct 24. Available from: https:\/\/news.abbvie.com\/news\/allergan-press-releases\/fda-approves-botox-onabotulinumtoxina-for-pediatric-patients-with-lower-limb-spasticity-excluding-spasticity-caused-by-cerebral-palsy.htm."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmrj.2018.06.004"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/pmrj.12240"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003789"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.2310\/7010.2006.00041"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.7916\/tohm.v0.749"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-015-1384-6"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2007.00818.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.phm.0000141131.66648.e9"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3233\/PRM-170516"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins7051629"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.4103\/aer.AER_182_18"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-4598(199805)21:5<653::aid-mus15>3.0.co;2-w"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2008.04.030"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880160913"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162206000387"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.23736\/S1973-9087.17.04664-0"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.23736\/S1973-9087.17.04667-6"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmr.2017.08.009"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14997-3"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2010.203364"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0387-7604(01)00394-1"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/jor.1100120603"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2017.11.013"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1017\/s0012162201000597"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1159\/000370245"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13108"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2017.12."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiomech.2015.10.006"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0000000000000907"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11110651"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-019-1906-8"}],"container-title":["Journal of Pediatric Rehabilitation Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/PRM-200716","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/PRM-200716","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/PRM-200716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:36:53Z","timestamp":1777610213000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/PRM-200716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6,19]]}},"alternative-id":["10.3233\/PRM-200716"],"URL":"https:\/\/doi.org\/10.3233\/prm-200716","relation":{},"ISSN":["1874-5393","1875-8894"],"issn-type":[{"value":"1874-5393","type":"print"},{"value":"1875-8894","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]}}}